EC145

2 Are Better Than 1: Endocyte Uses Diagnostics To Complements Its Drugs
Seeking Alpha
Sun, 09/29/13 - 01:41 pm
Endocyte
diagnostics
EC145
ovarian cancer
Endocyte Gets Big Deal But More Validation Needed
Seeking Alpha
Wed, 04/18/12 - 11:39 am
Merck
Endocyte
EC145
ovarian cancer
Early Submission = 60% Pop
Motley Fool
Sat, 03/17/12 - 10:34 am
Endocyte
EC145
ovarian cancer
Endocyte rockets 60% on EU update
Marketwatch
Thu, 03/15/12 - 09:10 am
Endocyte
Europe
ovarian cancer
EC145
EC20
Endocyte plunges on drug study results
Marketwatch
Tue, 12/13/11 - 11:56 am
Endocyte
EC145
ovarian cancer
No Post-IPO Blues for Endocyte
Seeking Alpha
Wed, 07/13/11 - 04:50 pm
IPOs
Endocyte
ovarian cancer
EC145
small molecule drugs
Endocyte's EC145 Meets Primary Endpoint in Phase 2 Study, Demonstrating 85 Percent (2.3 month) Improvement in Median Progression-Free Survival for Treatment of Platinum Resistant Ovarian Cancer
Yahoo/Globe NewsWire
Sun, 06/5/11 - 10:43 am
Endocyte
EC145
ovarian cancer